Michael J. Fox Foundation
Grifols Secures $21M MJFF Grant to Search for Early Parkinson's Biomarkers
Grifols subsidiary Alkahest will lead a pilot study to track proteomic changes in patient plasma samples over a 10-year period.
Alamar Biosciences, Michael J. Fox Foundation Partner on Parkinson's Research
The partners will use Alamar's NULISA proteomics platform to develop assays for identifying biomarkers linked to neuronal synuclein diseases including Parkinson's.
Global Parkinson's Genetics Program Signs up Psomagen for Large-Scale Whole-Genome Sequencing Study
Psomagen will sequence the genomes of approximately 80,000 individuals as part of a global effort to understand the genetic architecture of Parkinson's disease.
Centogene, Michael J. Fox Foundation to Study Genetic Risk Factors of Parkinson's Disease
The research project will leverage multiomic data in Centogene’s databank, which includes over 15,000 PD datasets from the company’s previous study.
Octave Bioscience Wins $10M Grant From Michael J. Fox Foundation
The firm will use the funds to develop a protein panel that can help assess disease activity and progression in individuals with Parkinson's.